Prostate cancer-normal

Product name Prostate cancer-normal
Cat. No. CA
Current version CA4
Data sheet CA4.pdf
No. of samples 49
No. of patients 40
Core diameter 2.0 mm
Section thickness 4 micrometer
Description prostate cancer: 40 cores
normal prostate: 9 cores
Price 244 EUR
320 USD
210 GBP

Prostate cancer-normal Prostate adenocarcinoma      Prostate cancer-normal Prostate adenocarcinoma 02Prostate cancer-normal Prostate adenocarcinoma 03

Product Related Literature

Prostate cancer is a form of glandular cancer onset, of the male reproductive system in the prostate. Growth is slow prostate most cancers, but in some cases of invasive cancer of the prostate. Tumor cells can be from prostate other body parts, especially in lymph nodes and bone to (spread) transition. Prostate cancer, the problem may be pain, difficulty urinating, during intercourse, or cause erectile dysfunction. Other symptoms, may occur during the later stages of the disease potentially.

Is detected less frequently than South Asia, East Asia, in Europe, in the United States, detection rate of prostate cancer varies greatly throughout the world especially. Prostate cancer tends to develop in men over the age of 50. Globally, (currently, the first of the second in the United Kingdom and the United States) it is a major cause of the sixth of cancer-related death in men. Prostate cancer is most common in developed countries has increased in developing countries. However, many men, not treated without symptoms never, prostate cancer die because of other unrelated eventually. Many factors, including the Food and genetic is involved in the development of prostate cancer.

It can be shown by biopsy presence of prostate cancer, symptoms, physical examination, prostate specific antigen or (PSA),. The prostate-specific antigen test, detection of cancer will increase, but it does not reduce the death rate. Because of the risk of re-treatment and over-diagnosis, such as prostate cancer, the U.S. Preventive Services Task Force, remain asymptomatic, which is recommended for screening for prostate cancer using the test PSA in 2012. USPSTF concluded that the potential benefits of the test is not exceeded expectations harm.

Management strategy for prostate cancer, should be guided by the severity of the disease. I can be low-risk tumor to track active surveillance very safely. For curative treatment, typically do not include surgery according to radiotherapy and various normal or cases of advanced disease rarely more, cryosurgery, hormone therapy, chemotherapy, and the (hormonal therapy Regardless, in some cases, it is reserved for applying a radiation of) possible. Several studies, masturbation, has been shown to reduce the risk of prostate cancer.

The base of human age, and health, extent of metastasis, appearance, and the reaction of the cancer to initial treatment are important in determining the prognosis of the disease under the microscope. Decision of whether to treat (cancer contained in the prostate) localized prostate cancer patients and radical is a compromise between the adverse effects to the expected beneficial to survival and quality of life of patients.

Usually do not cause symptoms early prostate cancer. But sometimes, the symptoms are similar to these diseases as benign prostatic hyperplasia such frequent prostate cancer. These include (painful urination) dysuria to start the steady stream (nocturia) frequent urination frequent urination at night, difficulty urine, maintain, and, hematuria (blood in the urine) is included . About one-third of patients diagnosed with prostate cancer between asymptomatic, two-thirds have more than one of these symptoms.

Prostate cancer is associated with dysuria prostate that surrounds the prostatic urethra. Therefore, changes in the gland can affect the urinary function directly. Secretion of the prostate and seminal of the urethra vas deferens deposits prostate as included in the content semen, prostate cancer, it’s performance sexual function and as difficult to obtain ejaculation and painful erection of such can cause problems.

Advanced prostate cancer, which can cause additional symptoms probably spread to other parts of the body. In many cases, (bones of the spine) spine, ribs and pelvis, the most common symptom is bone pain. Toward the proximal portion of the bone, cancer, spread to the bone of others, such as the femur in general. Prostate cancer of the spine, can be pressure and weakness of the legs, leading to fecal incontinence and urine, and spinal cord.

For a complete understanding of the causes of prostate cancer remains elusive. Obesity, age, the main risk factor is a family history. Prostate cancer is rare in women younger than 45 years, but with age, it becomes more frequent. Average age at diagnosis was 70. However, many people never know they have prostate cancer. Autopsy study of men in Uganda Sweden that died of other causes, Jamaica, Israel, German, Chinese, and have found prostate cancer 30 percent of the 50-year-old men and 80 percent of 70-year-old man. You appear to have a risk of developing the disease than men without prostate cancer in the family a man is a member of the family of first-degree of prostate cancer. This risk appears to be greater for men with a brother affected than men of his father affected. In the United States, mortality due to prostate cancer and new cases of about 230 000 of prostate cancer was 30,000 in 2005. A woman with high blood pressure, likely to develop prostate cancer is high. There is a possibility of a slight increase in prostate cancer is associated with a lack of exercise. In the 2010 study, I found that prostate basal cell is the most common site of origin of prostate cancer.